U.S. flag

An official website of the United States government

GTR Home > Tests > CentoIEM Panel

Indication

This is a clinical test intended for Help: Diagnosis

Clinical summary

Help

Imported from OMIM

Progressive leukoencephalopathy with ovarian failure is an autosomal recessive neurodegenerative disorder characterized by loss of motor and cognitive skills, usually with onset in young adulthood. Some patients may have a history of delayed motor development or learning difficulties in early childhood. Neurologic decline is severe, usually resulting in gait difficulties, ataxia, spasticity, and cognitive decline and dementia. Most patients lose speech and become wheelchair-bound or bedridden. Brain MRI shows progressive white matter signal abnormalities in the deep white matter. Affected females develop premature ovarian failure (summary by Dallabona et al., 2014).

Clinical features

Help

Imported from Human Phenotype Ontology (HPO)

  • Apraxia
  • Cerebellar ataxia
  • Depression
  • Dysarthria
  • Dystonic disorder
  • Periventricular leukomalacia
  • Premature ovarian insufficiency
  • Spasticity
  • Neurodegeneration
  • Nystagmus
  • Tremor
  • Leukoencephalopathy
  • Dementia
  • Loss of speech
  • Cerebellar atrophy
  • Progressive leukoencephalopathy
Show all

Conditions tested

Target population

Help

Not provided

Clinical validity

Help

This panel should be performed in all individuals suspected of having an overlapping clinical phenotype. Confirmation of a clinical diagnosis through genetic testing can allow for genetic counseling and may direct medical management. Genetic counseling can provide a patient and/or family with the natural history of the condition, identify at-risk family members, provide reproductive risks as well as preconception/prenatal options, and allow for appropriate referral for patient support and/or resources.

Citations

Not provided

Clinical utility

Help

Not provided

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.